GlassScriptPhysician profile
Karen M Abt
NPI 1144672577
$6,765.51
in general payments reported to CMS, 2019-2025
45 companies · $1,565 in 2025
The $1,565 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $904 · 2022: $1,417 · 2023: $1,403 · 2024: $1,477 · 2025: $1,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,444.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $882.83 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $654.33 | 2021-2025 | Botox, Lupron Depot |
| Merck Sharp & Dohme LLC | $485.46 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $475.85 | 2021-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $382.11 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $348.87 | 2025 | |
| Dendreon Pharmaceuticals LLC | $326.29 | 2022-2025 | Provenge |
| Teleflex LLC | $259.03 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $255.53 | 2022-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $242.14 | 2021-2025 | |
| Boston Scientific Corporation | $192.93 | 2021-2025 | Spaceoar Vue System - 10ml, Lithovue Elite |
| Amgen INC. | $187.88 | 2021-2024 | Prolia, Xgeva |
| Ferring Pharmaceuticals INC. | $175.05 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $157.22 | 2021-2025 | Speedicath |
| Myriad Genetic Laboratories, INC. | $152.50 | 2021-2025 | Prolaris, Precisetumor |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Abt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.